Last reviewed · How we verify
Placebo control drug
A placebo control drug produces no pharmacological effect and serves as an inert comparator in clinical trials.
A placebo control drug produces no pharmacological effect and serves as an inert comparator in clinical trials. Used for Control arm in phase 3 clinical trial (specific indication unknown).
At a glance
| Generic name | Placebo control drug |
|---|---|
| Also known as | Placebo drug |
| Sponsor | Guangzhou Women and Children's Medical Center |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo controls are inactive substances designed to match the appearance and administration route of the active investigational drug. They allow researchers to isolate the true therapeutic effect of the test drug by accounting for natural disease progression, patient expectation effects, and other non-pharmacological factors in clinical trial outcomes.
Approved indications
- Control arm in phase 3 clinical trial (specific indication unknown)
Common side effects
Key clinical trials
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. (PHASE2)
- Effect of Kinesio Taping Application in Addition to Pilates Exercises on Core Muscle Thickness, Cognition and Mental Fatigue in Individuals With Non-specific Low Back Pain (NA)
- Adenosine 2A Receptor Antagonism and AIH in ALS (PHASE1, PHASE2)
- Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) (PHASE2)
- Study of TGM-312-SC01 in Healthy Participants and Adults With MASH (PHASE1, PHASE2)
- IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes (PHASE3)
- Autonomic Determinants of POTS - Pilot1 (EARLY_PHASE1)
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo control drug CI brief — competitive landscape report
- Placebo control drug updates RSS · CI watch RSS
- Guangzhou Women and Children's Medical Center portfolio CI